Fact based stock research
Yuhan (KOSE:A000100)


Yuhan stock research in summary

eng.yuhan.co.kr


Yuhan shares have a BUY rating. They are safely financed and are good value, but show below average growth. We recommend buying and holding Yuhan shares.


Latest Obermatt Ranks


Country South Korea
Industry Pharmaceuticals
Index KOSPI
Size class Medium

June 8, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Research History: Yuhan

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
81
87
78
61
STOCK GROWTH RANKS
43
47
32
38
STOCK SAFETY RANKS
97
100
100
100
COMBINED STOCK RANKS
91
92
100
100

Last update of Combined Rank: 8-Jun-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Yuhan in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 8-Jun-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Yuhan; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
45
67
42
46
PROFIT GROWTH
51
44
44
33
STOCK RETURNS
70
35
62
54
CONSOLIDATED RANK: GROWTH
43
47
32
38

Financial reporting date of Growth Rank: 31-Mar-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Yuhan.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
86
86
90
84
REFINANCING
72
84
81
72
LIQUIDITY
100
100
100
100
CONSOLIDATED RANK: SAFETY
97
100
100
100

Financial reporting date of Safety Rank: 31-Mar-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Yuhan and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Yuhan from June 8, 2018.